A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease

A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease

ABSTRACT Off‐label use of biologic therapies in patients with pediatric inflammatory bowel disease (IBD) has seen an increase in utilization. In this paper, we review the current state of off‐label therapies in the pediatric IBD population. Real‐world use of ustekinumab (UST), vedolizumab (VDZ), upa...

Full description

Saved in:
Bibliographic Details
Main Authors: Yassin EL‐Najjar, Mary‐Joe Touma, Shuai Tan, Xiaoqin Zhou, Qi Liu
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Pediatric Discovery
Subjects:
biologic therapy
Crohn’s disease (CD)
pediatric inflammatory bowel disease 
small molecule
ulcerative colitis (UC)
Online Access:https://doi.org/10.1002/pdi3.70011
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/pdi3.70011

Similar Items